Industry Research Reports
Home > Reports > Chemical & Material > Pharmaceutical Grade Isonicotinamide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Pharmaceutical Grade Isonicotinamide - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Chemical & Material
Published Date: 2025-03-10
Pages: 100 Pages
Report ld: 4521309
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Pharmaceutical Grade Isonicotinamide Market Size(US$)
CAGR 2025-2031
4.7%
Market Size,2031
USD 35.7
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 27.1 million
Market Forecast in 2031(Value)
US$ 35.7 million
CAGR
4.7%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Pharmaceutical Grade Isonicotinamide was estimated to be worth US$ 26 million in 2024 and is forecast to a readjusted size of US$ 35.7 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Pharmaceutical grade isonicotinamide (pyridine-4-carboxamide) is the amide form of isonicotinic acid. It is an isomer of nicotinamide, with the carboxamide group positioned at the 4-position. Isonicotinamide is widely used in the pharmaceutical industry as a key intermediate in the synthesis of various drugs, particularly anti-tuberculosis medications and other therapeutic agents. Its high purity and stability meet stringent pharmaceutical standards, making it suitable for a range of high-demand medical applications.
North American market for Pharmaceutical Grade Isonicotinamide was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Pharmaceutical Grade Isonicotinamide was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Pharmaceutical Grade Isonicotinamide was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global key companies of Pharmaceutical Grade Isonicotinamide include Hebei Yanuo Bioscience, Veeprho, AK Scientific, SynZeal, Bide Pharmatech, Xiangshui Henryda Tech Chemical, Taizhou Quick Chemical, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Grade Isonicotinamide, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pharmaceutical Grade Isonicotinamide by region & country, by Type, and by Application.
The Pharmaceutical Grade Isonicotinamide market size, estimations, and forecasts are provided in terms of sales volume (kg) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Grade Isonicotinamide.
MARKET SEGMENTATION
By Company
- Hebei Yanuo Bioscience
- Veeprho
- AK Scientific
- SynZeal
- Bide Pharmatech
- Xiangshui Henryda Tech Chemical
- Taizhou Quick Chemical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity 99%
- Others
Segment by Application
- Cephalosporin Drug Intermediates
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pharmaceutical Grade Isonicotinamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pharmaceutical Grade Isonicotinamide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pharmaceutical Grade Isonicotinamide in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Pharmaceutical Grade Isonicotinamide Product Introduction
1.2 Global Pharmaceutical Grade Isonicotinamide Market Size Forecast
1.2.1 Global Pharmaceutical Grade Isonicotinamide Sales Value (2020-2031)
1.2.2 Global Pharmaceutical Grade Isonicotinamide Sales Volume (2020-2031)
1.2.3 Global Pharmaceutical Grade Isonicotinamide Sales Price (2020-2031)
1.3 Pharmaceutical Grade Isonicotinamide Market Trends & Drivers
1.3.1 Pharmaceutical Grade Isonicotinamide Industry Trends
1.3.2 Pharmaceutical Grade Isonicotinamide Market Drivers & Opportunity
1.3.3 Pharmaceutical Grade Isonicotinamide Market Challenges
1.3.4 Pharmaceutical Grade Isonicotinamide Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmaceutical Grade Isonicotinamide Players Revenue Ranking (2024)
2.2 Global Pharmaceutical Grade Isonicotinamide Revenue by Company (2020-2025)
2.3 Global Pharmaceutical Grade Isonicotinamide Players Sales Volume Ranking (2024)
2.4 Global Pharmaceutical Grade Isonicotinamide Sales Volume by Company Players (2020-2025)
2.5 Global Pharmaceutical Grade Isonicotinamide Average Price by Company (2020-2025)
2.6 Key Manufacturers Pharmaceutical Grade Isonicotinamide Manufacturing Base and Headquarters
2.7 Key Manufacturers Pharmaceutical Grade Isonicotinamide Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Pharmaceutical Grade Isonicotinamide
2.9 Pharmaceutical Grade Isonicotinamide Market Competitive Analysis
2.9.1 Pharmaceutical Grade Isonicotinamide Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Pharmaceutical Grade Isonicotinamide Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Grade Isonicotinamide as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity 99%
3.1.2 Others
3.2 Global Pharmaceutical Grade Isonicotinamide Sales Value by Type
3.2.1 Global Pharmaceutical Grade Isonicotinamide Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Pharmaceutical Grade Isonicotinamide Sales Value, by Type (2020-2031)
3.2.3 Global Pharmaceutical Grade Isonicotinamide Sales Value, by Type (%) (2020-2031)
3.3 Global Pharmaceutical Grade Isonicotinamide Sales Volume by Type
3.3.1 Global Pharmaceutical Grade Isonicotinamide Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Pharmaceutical Grade Isonicotinamide Sales Volume, by Type (2020-2031)
3.3.3 Global Pharmaceutical Grade Isonicotinamide Sales Volume, by Type (%) (2020-2031)
3.4 Global Pharmaceutical Grade Isonicotinamide Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Cephalosporin Drug Intermediates
4.1.2 Others
4.2 Global Pharmaceutical Grade Isonicotinamide Sales Value by Application
4.2.1 Global Pharmaceutical Grade Isonicotinamide Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Pharmaceutical Grade Isonicotinamide Sales Value, by Application (2020-2031)
4.2.3 Global Pharmaceutical Grade Isonicotinamide Sales Value, by Application (%) (2020-2031)
4.3 Global Pharmaceutical Grade Isonicotinamide Sales Volume by Application
4.3.1 Global Pharmaceutical Grade Isonicotinamide Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Pharmaceutical Grade Isonicotinamide Sales Volume, by Application (2020-2031)
4.3.3 Global Pharmaceutical Grade Isonicotinamide Sales Volume, by Application (%) (2020-2031)
4.4 Global Pharmaceutical Grade Isonicotinamide Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Pharmaceutical Grade Isonicotinamide Sales Value by Region
5.1.1 Global Pharmaceutical Grade Isonicotinamide Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Pharmaceutical Grade Isonicotinamide Sales Value by Region (2020-2025)
5.1.3 Global Pharmaceutical Grade Isonicotinamide Sales Value by Region (2026-2031)
5.1.4 Global Pharmaceutical Grade Isonicotinamide Sales Value by Region (%), (2020-2031)
5.2 Global Pharmaceutical Grade Isonicotinamide Sales Volume by Region
5.2.1 Global Pharmaceutical Grade Isonicotinamide Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Pharmaceutical Grade Isonicotinamide Sales Volume by Region (2020-2025)
5.2.3 Global Pharmaceutical Grade Isonicotinamide Sales Volume by Region (2026-2031)
5.2.4 Global Pharmaceutical Grade Isonicotinamide Sales Volume by Region (%), (2020-2031)
5.3 Global Pharmaceutical Grade Isonicotinamide Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Pharmaceutical Grade Isonicotinamide Sales Value, 2020-2031
5.4.2 North America Pharmaceutical Grade Isonicotinamide Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Pharmaceutical Grade Isonicotinamide Sales Value, 2020-2031
5.5.2 Europe Pharmaceutical Grade Isonicotinamide Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Pharmaceutical Grade Isonicotinamide Sales Value, 2020-2031
5.6.2 Asia Pacific Pharmaceutical Grade Isonicotinamide Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Pharmaceutical Grade Isonicotinamide Sales Value, 2020-2031
5.7.2 South America Pharmaceutical Grade Isonicotinamide Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Pharmaceutical Grade Isonicotinamide Sales Value, 2020-2031
5.8.2 Middle East & Africa Pharmaceutical Grade Isonicotinamide Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmaceutical Grade Isonicotinamide Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Pharmaceutical Grade Isonicotinamide Sales Value and Sales Volume
6.2.1 Key Countries/Regions Pharmaceutical Grade Isonicotinamide Sales Value, 2020-2031
6.2.2 Key Countries/Regions Pharmaceutical Grade Isonicotinamide Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Pharmaceutical Grade Isonicotinamide Sales Value, 2020-2031
6.3.2 United States Pharmaceutical Grade Isonicotinamide Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Pharmaceutical Grade Isonicotinamide Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Pharmaceutical Grade Isonicotinamide Sales Value, 2020-2031
6.4.2 Europe Pharmaceutical Grade Isonicotinamide Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Pharmaceutical Grade Isonicotinamide Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Pharmaceutical Grade Isonicotinamide Sales Value, 2020-2031
6.5.2 China Pharmaceutical Grade Isonicotinamide Sales Value by Type (%), 2024 VS 2031
6.5.3 China Pharmaceutical Grade Isonicotinamide Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Pharmaceutical Grade Isonicotinamide Sales Value, 2020-2031
6.6.2 Japan Pharmaceutical Grade Isonicotinamide Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Pharmaceutical Grade Isonicotinamide Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Pharmaceutical Grade Isonicotinamide Sales Value, 2020-2031
6.7.2 South Korea Pharmaceutical Grade Isonicotinamide Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Pharmaceutical Grade Isonicotinamide Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmaceutical Grade Isonicotinamide Sales Value, 2020-2031
6.8.2 Southeast Asia Pharmaceutical Grade Isonicotinamide Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Pharmaceutical Grade Isonicotinamide Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Pharmaceutical Grade Isonicotinamide Sales Value, 2020-2031
6.9.2 India Pharmaceutical Grade Isonicotinamide Sales Value by Type (%), 2024 VS 2031
6.9.3 India Pharmaceutical Grade Isonicotinamide Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Hebei Yanuo Bioscience
7.1.1 Hebei Yanuo Bioscience Company Information
7.1.2 Hebei Yanuo Bioscience Introduction and Business Overview
7.1.3 Hebei Yanuo Bioscience Pharmaceutical Grade Isonicotinamide Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Hebei Yanuo Bioscience Pharmaceutical Grade Isonicotinamide Product Offerings
7.1.5 Hebei Yanuo Bioscience Recent Development
7.2 Veeprho
7.2.1 Veeprho Company Information
7.2.2 Veeprho Introduction and Business Overview
7.2.3 Veeprho Pharmaceutical Grade Isonicotinamide Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Veeprho Pharmaceutical Grade Isonicotinamide Product Offerings
7.2.5 Veeprho Recent Development
7.3 AK Scientific
7.3.1 AK Scientific Company Information
7.3.2 AK Scientific Introduction and Business Overview
7.3.3 AK Scientific Pharmaceutical Grade Isonicotinamide Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 AK Scientific Pharmaceutical Grade Isonicotinamide Product Offerings
7.3.5 AK Scientific Recent Development
7.4 SynZeal
7.4.1 SynZeal Company Information
7.4.2 SynZeal Introduction and Business Overview
7.4.3 SynZeal Pharmaceutical Grade Isonicotinamide Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 SynZeal Pharmaceutical Grade Isonicotinamide Product Offerings
7.4.5 SynZeal Recent Development
7.5 Bide Pharmatech
7.5.1 Bide Pharmatech Company Information
7.5.2 Bide Pharmatech Introduction and Business Overview
7.5.3 Bide Pharmatech Pharmaceutical Grade Isonicotinamide Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Bide Pharmatech Pharmaceutical Grade Isonicotinamide Product Offerings
7.5.5 Bide Pharmatech Recent Development
7.6 Xiangshui Henryda Tech Chemical
7.6.1 Xiangshui Henryda Tech Chemical Company Information
7.6.2 Xiangshui Henryda Tech Chemical Introduction and Business Overview
7.6.3 Xiangshui Henryda Tech Chemical Pharmaceutical Grade Isonicotinamide Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Xiangshui Henryda Tech Chemical Pharmaceutical Grade Isonicotinamide Product Offerings
7.6.5 Xiangshui Henryda Tech Chemical Recent Development
7.7 Taizhou Quick Chemical
7.7.1 Taizhou Quick Chemical Company Information
7.7.2 Taizhou Quick Chemical Introduction and Business Overview
7.7.3 Taizhou Quick Chemical Pharmaceutical Grade Isonicotinamide Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Taizhou Quick Chemical Pharmaceutical Grade Isonicotinamide Product Offerings
7.7.5 Taizhou Quick Chemical Recent Development
8 Industry Chain Analysis
8.1 Pharmaceutical Grade Isonicotinamide Industrial Chain
8.2 Pharmaceutical Grade Isonicotinamide Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pharmaceutical Grade Isonicotinamide Sales Model
8.5.2 Sales Channel
8.5.3 Pharmaceutical Grade Isonicotinamide Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Pharmaceutical Grade Isonicotinamide Market Trends
Table 2. Pharmaceutical Grade Isonicotinamide Market Drivers & Opportunity
Table 3. Pharmaceutical Grade Isonicotinamide Market Challenges
Table 4. Pharmaceutical Grade Isonicotinamide Market Restraints
Table 5. Global Pharmaceutical Grade Isonicotinamide Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Pharmaceutical Grade Isonicotinamide Revenue Market Share by Company (2020-2025)
Table 7. Global Pharmaceutical Grade Isonicotinamide Sales Volume by Company (2020-2025) & (kg)
Table 8. Global Pharmaceutical Grade Isonicotinamide Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Pharmaceutical Grade Isonicotinamide Price by Company (2020-2025) & (US$/kg)
Table 10. Key Manufacturers Pharmaceutical Grade Isonicotinamide Manufacturing Base and Headquarters
Table 11. Key Manufacturers Pharmaceutical Grade Isonicotinamide Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Pharmaceutical Grade Isonicotinamide
Table 13. Global Pharmaceutical Grade Isonicotinamide Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Grade Isonicotinamide as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Pharmaceutical Grade Isonicotinamide Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Pharmaceutical Grade Isonicotinamide Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Pharmaceutical Grade Isonicotinamide Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Pharmaceutical Grade Isonicotinamide Sales Market Share in Value by Type (2020-2025)
Table 20. Global Pharmaceutical Grade Isonicotinamide Sales Market Share in Value by Type (2026-2031)
Table 21. Global Pharmaceutical Grade Isonicotinamide Sales Volume by Type: 2020 VS 2024 VS 2031 (kg)
Table 22. Global Pharmaceutical Grade Isonicotinamide Sales Volume by Type (2020-2025) & (kg)
Table 23. Global Pharmaceutical Grade Isonicotinamide Sales Volume by Type (2026-2031) & (kg)
Table 24. Global Pharmaceutical Grade Isonicotinamide Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Pharmaceutical Grade Isonicotinamide Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Pharmaceutical Grade Isonicotinamide Price by Type (2020-2025) & (US$/kg)
Table 27. Global Pharmaceutical Grade Isonicotinamide Price by Type (2026-2031) & (US$/kg)
Table 28. Global Pharmaceutical Grade Isonicotinamide Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Pharmaceutical Grade Isonicotinamide Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Pharmaceutical Grade Isonicotinamide Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Pharmaceutical Grade Isonicotinamide Sales Market Share in Value by Application (2020-2025)
Table 32. Global Pharmaceutical Grade Isonicotinamide Sales Market Share in Value by Application (2026-2031)
Table 33. Global Pharmaceutical Grade Isonicotinamide Sales Volume by Application: 2020 VS 2024 VS 2031 (kg)
Table 34. Global Pharmaceutical Grade Isonicotinamide Sales Volume by Application (2020-2025) & (kg)
Table 35. Global Pharmaceutical Grade Isonicotinamide Sales Volume by Application (2026-2031) & (kg)
Table 36. Global Pharmaceutical Grade Isonicotinamide Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Pharmaceutical Grade Isonicotinamide Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Pharmaceutical Grade Isonicotinamide Price by Application (2020-2025) & (US$/kg)
Table 39. Global Pharmaceutical Grade Isonicotinamide Price by Application (2026-2031) & (US$/kg)
Table 40. Global Pharmaceutical Grade Isonicotinamide Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Pharmaceutical Grade Isonicotinamide Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Pharmaceutical Grade Isonicotinamide Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Pharmaceutical Grade Isonicotinamide Sales Value by Region (2020-2025) & (%)
Table 44. Global Pharmaceutical Grade Isonicotinamide Sales Value by Region (2026-2031) & (%)
Table 45. Global Pharmaceutical Grade Isonicotinamide Sales Volume by Region (kg): 2020 VS 2024 VS 2031
Table 46. Global Pharmaceutical Grade Isonicotinamide Sales Volume by Region (2020-2025) & (kg)
Table 47. Global Pharmaceutical Grade Isonicotinamide Sales Volume by Region (2026-2031) & (kg)
Table 48. Global Pharmaceutical Grade Isonicotinamide Sales Volume by Region (2020-2025) & (%)
Table 49. Global Pharmaceutical Grade Isonicotinamide Sales Volume by Region (2026-2031) & (%)
Table 50. Global Pharmaceutical Grade Isonicotinamide Average Price by Region (2020-2025) & (US$/kg)
Table 51. Global Pharmaceutical Grade Isonicotinamide Average Price by Region (2026-2031) & (US$/kg)
Table 52. Key Countries/Regions Pharmaceutical Grade Isonicotinamide Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Pharmaceutical Grade Isonicotinamide Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Pharmaceutical Grade Isonicotinamide Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Pharmaceutical Grade Isonicotinamide Sales Volume, (2020-2025) & (kg)
Table 56. Key Countries/Regions Pharmaceutical Grade Isonicotinamide Sales Volume, (2026-2031) & (kg)
Table 57. Hebei Yanuo Bioscience Company Information
Table 58. Hebei Yanuo Bioscience Introduction and Business Overview
Table 59. Hebei Yanuo Bioscience Pharmaceutical Grade Isonicotinamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 60. Hebei Yanuo Bioscience Pharmaceutical Grade Isonicotinamide Product Offerings
Table 61. Hebei Yanuo Bioscience Recent Development
Table 62. Veeprho Company Information
Table 63. Veeprho Introduction and Business Overview
Table 64. Veeprho Pharmaceutical Grade Isonicotinamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 65. Veeprho Pharmaceutical Grade Isonicotinamide Product Offerings
Table 66. Veeprho Recent Development
Table 67. AK Scientific Company Information
Table 68. AK Scientific Introduction and Business Overview
Table 69. AK Scientific Pharmaceutical Grade Isonicotinamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 70. AK Scientific Pharmaceutical Grade Isonicotinamide Product Offerings
Table 71. AK Scientific Recent Development
Table 72. SynZeal Company Information
Table 73. SynZeal Introduction and Business Overview
Table 74. SynZeal Pharmaceutical Grade Isonicotinamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 75. SynZeal Pharmaceutical Grade Isonicotinamide Product Offerings
Table 76. SynZeal Recent Development
Table 77. Bide Pharmatech Company Information
Table 78. Bide Pharmatech Introduction and Business Overview
Table 79. Bide Pharmatech Pharmaceutical Grade Isonicotinamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 80. Bide Pharmatech Pharmaceutical Grade Isonicotinamide Product Offerings
Table 81. Bide Pharmatech Recent Development
Table 82. Xiangshui Henryda Tech Chemical Company Information
Table 83. Xiangshui Henryda Tech Chemical Introduction and Business Overview
Table 84. Xiangshui Henryda Tech Chemical Pharmaceutical Grade Isonicotinamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 85. Xiangshui Henryda Tech Chemical Pharmaceutical Grade Isonicotinamide Product Offerings
Table 86. Xiangshui Henryda Tech Chemical Recent Development
Table 87. Taizhou Quick Chemical Company Information
Table 88. Taizhou Quick Chemical Introduction and Business Overview
Table 89. Taizhou Quick Chemical Pharmaceutical Grade Isonicotinamide Sales (kg), Revenue (US$ Million), Price (US$/kg) and Gross Margin (2020-2025)
Table 90. Taizhou Quick Chemical Pharmaceutical Grade Isonicotinamide Product Offerings
Table 91. Taizhou Quick Chemical Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Pharmaceutical Grade Isonicotinamide Downstream Customers
Table 95. Pharmaceutical Grade Isonicotinamide Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Pharmaceutical Grade Isonicotinamide Product Picture
Figure 2. Global Pharmaceutical Grade Isonicotinamide Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Pharmaceutical Grade Isonicotinamide Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Pharmaceutical Grade Isonicotinamide Sales Volume (2020-2031) & (kg)
Figure 5. Global Pharmaceutical Grade Isonicotinamide Sales Price (2020-2031) & (US$/kg)
Figure 6. Pharmaceutical Grade Isonicotinamide Report Years Considered
Figure 7. Global Pharmaceutical Grade Isonicotinamide Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Pharmaceutical Grade Isonicotinamide Players Sales Volume Ranking (2024) & (kg)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Pharmaceutical Grade Isonicotinamide Revenue in 2024
Figure 10. Pharmaceutical Grade Isonicotinamide Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Purity 99% Picture
Figure 12. Others Picture
Figure 13. Global Pharmaceutical Grade Isonicotinamide Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Pharmaceutical Grade Isonicotinamide Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Pharmaceutical Grade Isonicotinamide Sales Volume by Type (2020 VS 2024 VS 2031) & (kg)
Figure 16. Global Pharmaceutical Grade Isonicotinamide Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Pharmaceutical Grade Isonicotinamide Price by Type (2020-2031) & (US$/kg)
Figure 18. Product Picture of Cephalosporin Drug Intermediates
Figure 19. Product Picture of Others
Figure 20. Global Pharmaceutical Grade Isonicotinamide Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 21. Global Pharmaceutical Grade Isonicotinamide Sales Value Market Share by Application, 2024 & 2031
Figure 22. Global Pharmaceutical Grade Isonicotinamide Sales Volume by Application (2020 VS 2024 VS 2031) & (kg)
Figure 23. Global Pharmaceutical Grade Isonicotinamide Sales Volume Market Share by Application, 2024 & 2031
Figure 24. Global Pharmaceutical Grade Isonicotinamide Price by Application (2020-2031) & (US$/kg)
Figure 25. North America Pharmaceutical Grade Isonicotinamide Sales Value (2020-2031) & (US$ Million)
Figure 26. North America Pharmaceutical Grade Isonicotinamide Sales Value by Country (%), 2024 VS 2031
Figure 27. Europe Pharmaceutical Grade Isonicotinamide Sales Value, (2020-2031) & (US$ Million)
Figure 28. Europe Pharmaceutical Grade Isonicotinamide Sales Value by Country (%), 2024 VS 2031
Figure 29. Asia Pacific Pharmaceutical Grade Isonicotinamide Sales Value, (2020-2031) & (US$ Million)
Figure 30. Asia Pacific Pharmaceutical Grade Isonicotinamide Sales Value by Region (%), 2024 VS 2031
Figure 31. South America Pharmaceutical Grade Isonicotinamide Sales Value, (2020-2031) & (US$ Million)
Figure 32. South America Pharmaceutical Grade Isonicotinamide Sales Value by Country (%), 2024 VS 2031
Figure 33. Middle East & Africa Pharmaceutical Grade Isonicotinamide Sales Value, (2020-2031) & (US$ Million)
Figure 34. Middle East & Africa Pharmaceutical Grade Isonicotinamide Sales Value by Country (%), 2024 VS 2031
Figure 35. Key Countries/Regions Pharmaceutical Grade Isonicotinamide Sales Value (%), (2020-2031)
Figure 36. Key Countries/Regions Pharmaceutical Grade Isonicotinamide Sales Volume (%), (2020-2031)
Figure 37. United States Pharmaceutical Grade Isonicotinamide Sales Value, (2020-2031) & (US$ Million)
Figure 38. United States Pharmaceutical Grade Isonicotinamide Sales Value by Type (%), 2024 VS 2031
Figure 39. United States Pharmaceutical Grade Isonicotinamide Sales Value by Application (%), 2024 VS 2031
Figure 40. Europe Pharmaceutical Grade Isonicotinamide Sales Value, (2020-2031) & (US$ Million)
Figure 41. Europe Pharmaceutical Grade Isonicotinamide Sales Value by Type (%), 2024 VS 2031
Figure 42. Europe Pharmaceutical Grade Isonicotinamide Sales Value by Application (%), 2024 VS 2031
Figure 43. China Pharmaceutical Grade Isonicotinamide Sales Value, (2020-2031) & (US$ Million)
Figure 44. China Pharmaceutical Grade Isonicotinamide Sales Value by Type (%), 2024 VS 2031
Figure 45. China Pharmaceutical Grade Isonicotinamide Sales Value by Application (%), 2024 VS 2031
Figure 46. Japan Pharmaceutical Grade Isonicotinamide Sales Value, (2020-2031) & (US$ Million)
Figure 47. Japan Pharmaceutical Grade Isonicotinamide Sales Value by Type (%), 2024 VS 2031
Figure 48. Japan Pharmaceutical Grade Isonicotinamide Sales Value by Application (%), 2024 VS 2031
Figure 49. South Korea Pharmaceutical Grade Isonicotinamide Sales Value, (2020-2031) & (US$ Million)
Figure 50. South Korea Pharmaceutical Grade Isonicotinamide Sales Value by Type (%), 2024 VS 2031
Figure 51. South Korea Pharmaceutical Grade Isonicotinamide Sales Value by Application (%), 2024 VS 2031
Figure 52. Southeast Asia Pharmaceutical Grade Isonicotinamide Sales Value, (2020-2031) & (US$ Million)
Figure 53. Southeast Asia Pharmaceutical Grade Isonicotinamide Sales Value by Type (%), 2024 VS 2031
Figure 54. Southeast Asia Pharmaceutical Grade Isonicotinamide Sales Value by Application (%), 2024 VS 2031
Figure 55. India Pharmaceutical Grade Isonicotinamide Sales Value, (2020-2031) & (US$ Million)
Figure 56. India Pharmaceutical Grade Isonicotinamide Sales Value by Type (%), 2024 VS 2031
Figure 57. India Pharmaceutical Grade Isonicotinamide Sales Value by Application (%), 2024 VS 2031
Figure 58. Pharmaceutical Grade Isonicotinamide Industrial Chain
Figure 59. Pharmaceutical Grade Isonicotinamide Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of Pharmaceutical Grade Isonicotinamide in 2025?
The global market size of Pharmaceutical Grade Isonicotinamide in 2025 was 27.1 Million USD.
Which companies rank high in the global Pharmaceutical Grade Isonicotinamide market?
What was the global market size of Pharmaceutical Grade Isonicotinamide in 2031?
What is the annual compound growth rate of the global Pharmaceutical Grade Isonicotinamide market size from 2025 to 2031?
Which region is expected to have the highest market share?
Related Reports
Global Pharmaceutical Grade Isonicotinamide Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Pharmaceutical Grade Isonicotinamide market is projected to grow from US$ 27.1 million in 2025 to US$ 37.26 million by 2032, at a CAGR of 4.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 138
USD 4900.00
(Single User License)
Global Pharmaceutical Grade Isonicotinamide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Grade Isonicotinamide market size was US$ 27.1 million in 2025 and is forecast to reach a readjusted size of US$ 37.26 million by 2032 with a CAGR of 4.7% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 79
USD 4250.00
(Single User License)
Pharmaceutical Grade Isonicotinamide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Grade Isonicotinamide was estimated to be worth US$ 27.1 million in 2025 and is projected to reach US$ 37.26 million, growing at a CAGR of 4.7% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 104
USD 3950.00
(Single User License)
Global Pharmaceutical Grade Isonicotinamide Market Research Report 2026
The global Pharmaceutical Grade Isonicotinamide market was valued at US$ 27.1 million in 2025 and is anticipated to reach US$ 37.26 million by 2032, at a CAGR of 4.7% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 132
USD 2900.00
(Single User License)
Global Pharmaceutical Grade Isonicotinamide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Grade Isonicotinamide market is projected to grow from US$ 26 million in 2024 to US$ 35.7 million by 2031, at a CAGR of 4.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 132
USD 4900.00
(Single User License)
Global Pharmaceutical Grade Isonicotinamide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Grade Isonicotinamide market size was US$ 26 million in 2024 and is forecast to a readjusted size of US$ 35.7 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 79
USD 4250.00
(Single User License)
Global Pharmaceutical Grade Isonicotinamide Market Research Report 2025
The global market for Pharmaceutical Grade Isonicotinamide was valued at US$ 26 million in the year 2024 and is projected to reach a revised size of US$ 35.7 million by 2031, growing at a CAGR of 4.7% during the forecast period.
Published Date: 2025-03-10
Pages: 92
USD 2900.00
(Single User License)
Global Pharmaceutical Grade Isonicotinamide Market Research Report 2024
The global market for Pharmaceutical Grade Isonicotinamide was valued at US$ 25 million in the year 2023 and is projected to reach a revised size of US$ 34.3 million by 2030, growing at a CAGR of 4.7% during the forecast period.
Published Date: 2025-01-01
Pages: 92
USD 2900.00
(Single User License)
Global Pharmaceutical Grade Isonicotinamide Market Insights, Forecast to 2030
Valued at US$ 26 million in 2024, the global Pharmaceutical Grade Isonicotinamide market is forecast to reach US$ 34.3 million by 2030, at a CAGR of 4.7% during the forecast period.
Published Date: 2025-01-01
Pages: 149
USD 4900.00
(Single User License)
Global and United States Pharmaceutical Grade Isonicotinamide Market Report & Forecast 2024-2030
The global Pharmaceutical Grade Isonicotinamide revenue was US$ 25 million in 2023 and is forecast to a readjusted size of US$ 34.3 million by 2030 with a CAGR of 4.7% during the review period (2024-2030).
Published Date: 2025-01-01
Pages: 113
USD 4350.00
(Single User License)
Global Pharmaceutical Grade Isonicotinamide Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Pharmaceutical Grade Isonicotinamide market is projected to grow from US$ 27.1 million in 2025 to US$ 37.26 million by 2032, at a CAGR of 4.7% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 138
USD 4900.00 (Single User License)Global Pharmaceutical Grade Isonicotinamide Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Pharmaceutical Grade Isonicotinamide market size was US$ 27.1 million in 2025 and is forecast to reach a readjusted size of US$ 37.26 million by 2032 with a CAGR of 4.7% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 79
USD 4250.00 (Single User License)Pharmaceutical Grade Isonicotinamide- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Pharmaceutical Grade Isonicotinamide was estimated to be worth US$ 27.1 million in 2025 and is projected to reach US$ 37.26 million, growing at a CAGR of 4.7% from 2026 to 2032.
Published: 2026-01-19
Pages: 104
USD 3950.00 (Single User License)Global Pharmaceutical Grade Isonicotinamide Market Research Report 2026
The global Pharmaceutical Grade Isonicotinamide market was valued at US$ 27.1 million in 2025 and is anticipated to reach US$ 37.26 million by 2032, at a CAGR of 4.7% from 2026 to 2032.
Published: 2026-01-08
Pages: 132
USD 2900.00 (Single User License)Global Pharmaceutical Grade Isonicotinamide Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Pharmaceutical Grade Isonicotinamide market is projected to grow from US$ 26 million in 2024 to US$ 35.7 million by 2031, at a CAGR of 4.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 132
USD 4900.00 (Single User License)Global Pharmaceutical Grade Isonicotinamide Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Pharmaceutical Grade Isonicotinamide market size was US$ 26 million in 2024 and is forecast to a readjusted size of US$ 35.7 million by 2031 with a CAGR of 4.7% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 79
USD 4250.00 (Single User License)Global Pharmaceutical Grade Isonicotinamide Market Research Report 2025
The global market for Pharmaceutical Grade Isonicotinamide was valued at US$ 26 million in the year 2024 and is projected to reach a revised size of US$ 35.7 million by 2031, growing at a CAGR of 4.7% during the forecast period.
Published: 2025-03-10
Pages: 92
USD 2900.00 (Single User License)Global Pharmaceutical Grade Isonicotinamide Market Research Report 2024
The global market for Pharmaceutical Grade Isonicotinamide was valued at US$ 25 million in the year 2023 and is projected to reach a revised size of US$ 34.3 million by 2030, growing at a CAGR of 4.7% during the forecast period.
Published: 2025-01-01
Pages: 92
USD 2900.00 (Single User License)Global Pharmaceutical Grade Isonicotinamide Market Insights, Forecast to 2030
Valued at US$ 26 million in 2024, the global Pharmaceutical Grade Isonicotinamide market is forecast to reach US$ 34.3 million by 2030, at a CAGR of 4.7% during the forecast period.
Published: 2025-01-01
Pages: 149
USD 4900.00 (Single User License)Global and United States Pharmaceutical Grade Isonicotinamide Market Report & Forecast 2024-2030
The global Pharmaceutical Grade Isonicotinamide revenue was US$ 25 million in 2023 and is forecast to a readjusted size of US$ 34.3 million by 2030 with a CAGR of 4.7% during the review period (2024-2030).
Published: 2025-01-01
Pages: 113
USD 4350.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now